Regulation of estrus and ovulation in gilts
A technology for gilts and estrus, which is applied to the composition of estrus and ovulation, the field of controlled-release preparations for estrus and ovulation regulation of gilts, and can solve endometriosis, unsanitary conditions, a large number of boars, etc. question
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0053] The invention will be further understood by reference to the following non-limiting examples. Example 1: Regulating estrus and ovulation experiment design of gilts with estradiol microspheres
[0054] A controlled study in 180-day-old gilts was performed to demonstrate that a single dose injection of the controlled-release microsphere formulation must be able to induce false pregnancy, followed by PG 600 TM Induces estrous ovulation in youth. Four doses of estradiol microspheres were evaluated in this study. Studies have also demonstrated that Lutalyse TM (PGF2α, 10 mg) could induce controlled estrus in pseudopregnant gilts at day 59 after treatment in a controlled manner to induce luteal breakdown and estrus.
[0055] The study was designed as a parallel group scheme. The same number of gilts were randomly divided into the following treatment groups: placebo group; polylactide microspheres group containing 12.5 mg 17β-estradiol; 25 mg 17β-estradiol group; 50 mg 17β...
Embodiment 2
[0082] Controlled-release polylactide microspheres designed to release physiologically effective levels of 17β-estradiol over a period of 16 to 26 days were able to successfully induce pseudopregnancy in gilts for more than 50 days. Following induction of pseudopregnancy, pseudopregnancy can be terminated and estrus induced by administering a commercially available analogue of PGF2[alpha]. The advantage of inducing pseudopregnancy followed by estrus induction is that the reproductive pattern of a large number of gilts can be controlled. Example 2: Overview of biodegradable drug delivery systems for estradiol in sucrose acetate isobutyrate formulations
[0083] The aim of this study was to prepare sucrose acetate isobutyrate (SAIB)-based formulations of estradiol with in vivo pharmacokinetic release profiles similar to those obtained using biodegradable microsphere formulations. The delivery system uses SAIB as a high viscosity matrix compound to provide controlled release of ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com